Showing results (61-70 of 78) with videos related to
Sort By:
Pageof 8
Bioorganic Chemistry|February 10, 2026
Identification of EEF1A1 as a therapeutic target in TNBC: Anticancer action of a novel Penicillide-derived inhibitor through ribosomal protein regulationJing Yu, Ru-Yi Chen, Yan-Jun Liu, et al.Marine Drugs|October 25, 2024
Marine Staurosporine Analogues: Activity and Target Identification in Triple-Negative Breast CancerRu-Yi Chen, Li-Jian Ding, Yan-Jun Liu, et al.Biomolecules|May 24, 2024
The Emerging Role of Ubiquitin-Specific Protease 36 (USP36) in Cancer and BeyondMeng-Yao Niu, Yan-Jun Liu, Jin-Jin Shi, et al.International Immunopharmacology|January 19, 2026
Cytochalasin Z16 reshapes macrophage responses to intracellular pathogens: HSPA5-targeted immunotherapy against zoonotic and foodborne Edwardsiella tardaJin-Jin Shi, Jing Yu, Ran Wang, et al.Cellular & Molecular Biology Letters|March 5, 2024
Curriculum vitae of CUG binding protein 1 (CELF1) in homeostasis and diseases: a systematic reviewWan-Jia Qin, Jin-Jin Shi, Ru-Yi Chen, et al.Frontiers in Oncology|September 19, 2022
Berberine as a potential agent for breast cancer therapyXiao-Dan Zhong, Li-Juan Chen, Xin-Yang Xu, et al.European Journal of Medicinal Chemistry|September 23, 2021
Pharmacological inhibition of KDM5A for cancer treatmentGuan-Jun Yang, Jia Wu, Liang Miao, et al.Bioorganic Chemistry|February 8, 2023
The role of lysine-specific demethylase 6A (KDM6A) in tumorigenesis and its therapeutic potentials in cancer therapyLi-Juan Chen, Xin-Yang Xu, Xiao-Dan Zhong, et al.European Journal of Medicinal Chemistry|November 30, 2024
PRMT7 in cancer: Structure, effects, and therapeutic potentialsGuan-Jun Yang, Yan-Jun Liu, Ru-Yi Chen, et al.Nature Communications|September 7, 2016
LECT2 drives haematopoietic stem cell expansion and mobilization via regulating the macrophages and osteolineage cellsXin-Jiang Lu, Qiang Chen, Ye-Jing Rong, et al.Pageof 8